Press Release | NeoGenomics Laboratories

November 6, 2023

NeoGenomics Reports Third Quarter 2023 Results

October 24, 2023

NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios

October 17, 2023

NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023

August 8, 2023

NeoGenomics Reports Second Quarter 2023 Results

July 27, 2023

NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer

July 18, 2023

NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023

June 29, 2023

NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors

June 15, 2023

NeoGenomics' RaDaR Assay for Minimal Residual Disease Receives First Commercial Coverage

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients